» Articles » PMID: 29186791

How Do PrP Prions Spread Between Host Species, and Within Hosts?

Overview
Journal Pathogens
Date 2017 Dec 1
PMID 29186791
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are sub-acute neurodegenerative diseases that affect humans and some domestic and free-ranging animals. Infectious prion agents are considered to comprise solely of abnormally folded isoforms of the cellular prion protein known as PrP. Pathology during prion disease is restricted to the central nervous system where it causes extensive neurodegeneration and ultimately leads to the death of the host. The first half of this review provides a thorough account of our understanding of the various ways in which PrP prions may spread between individuals within a population, both horizontally and vertically. Many natural prion diseases are acquired peripherally, such as by oral exposure, lesions to skin or mucous membranes, and possibly also via the nasal cavity. Following peripheral exposure, some prions accumulate to high levels within the secondary lymphoid organs as they make their journey from the site of infection to the brain, a process termed neuroinvasion. The replication of PrP prions within secondary lymphoid organs is important for their efficient spread to the brain. The second half of this review describes the key tissues, cells and molecules which are involved in the propagation of PrP prions from peripheral sites of exposure (such as the lumen of the intestine) to the brain. This section also considers how additional factors such as inflammation and aging might influence prion disease susceptibility.

Citing Articles

Myo1d promotes alpha-synuclein transfer from brain microvascular endothelial cells to pericytes through tunneling nanotubes.

Duan Q, Zhang Q, Nie K, Huang R, Yang J, He P iScience. 2023; 26(8):107458.

PMID: 37575183 PMC: 10416064. DOI: 10.1016/j.isci.2023.107458.


Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease.

Dolgacheva L, Zinchenko V, Goncharov N Int J Mol Sci. 2022; 23(21).

PMID: 36361826 PMC: 9657547. DOI: 10.3390/ijms232113043.


Neurons and Astrocytes Elicit Brain Region Specific Transcriptional Responses to Prion Disease in the Murine CA1 and Thalamus.

Slota J, Medina S, Frost K, Booth S Front Neurosci. 2022; 16:918811.

PMID: 35651626 PMC: 9149297. DOI: 10.3389/fnins.2022.918811.


PrP (58-93) peptide from unstructured N-terminal domain of human prion protein forms amyloid-like fibrillar structures in the presence of Zn ions.

Gielnik M, Pietralik Z, Zhukov I, Szymanska A, Kwiatek W, Kozak M RSC Adv. 2022; 9(39):22211-22219.

PMID: 35519468 PMC: 9066832. DOI: 10.1039/c9ra01510h.


Deletion of Does Not Alter Prion Disease Tempo or Spread in Mouse Brain.

Race B, Williams K, Baune C, Striebel J, Winkler C, Carroll J Viruses. 2021; 13(7).

PMID: 34372599 PMC: 8310152. DOI: 10.3390/v13071391.


References
1.
Sethi S, Kerksiek K, Brocker T, Kretzschmar H . Role of the CD8+ dendritic cell subset in transmission of prions. J Virol. 2007; 81(9):4877-80. PMC: 1900152. DOI: 10.1128/JVI.02345-06. View

2.
Bradford B, Crocker P, Mabbott N . Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169). Immunology. 2014; 143(1):120-9. PMC: 4137961. DOI: 10.1111/imm.12294. View

3.
Brown P . Creutzfeldt-Jakob disease: blood infectivity and screening tests. Semin Hematol. 2001; 38(4 Suppl 9):2-6. DOI: 10.1016/s0037-1963(01)90130-1. View

4.
Tobler I, Gaus S, Deboer T, Achermann P, Fischer M, Rulicke T . Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 1996; 380(6575):639-42. DOI: 10.1038/380639a0. View

5.
Wang F, Wang X, Yuan C, Ma J . Generating a prion with bacterially expressed recombinant prion protein. Science. 2010; 327(5969):1132-5. PMC: 2893558. DOI: 10.1126/science.1183748. View